| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.09 |